To analyze consequences of upregulated IFN pathway and enhanced antigen presentation resulting from METTL3 inhibition in tumor cells, the authors employed an antigen-specific co-culture system consisting of tumor cells expressing the model antigen ovalbumin (OVA) and OVA-specific transgenic CD8+ T-cells (OT-I). The gene discussed is METTL3; the disease is neoplasm.